BDSX · Biodesix Inc
United States · RS rating 68 · As of 2026-11-03
| Price | 21.05 USD |
|---|---|
| 1-day change | -3.4% |
| RS rating (overall / 1M / 3M / 12M) | 68 / 14 / 50 / 97 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 40 / 30 / 52 |
| Industry group (rank) | Medical-Services (63) |
| EPS growth Q/Q | +57.8% |
| Sales growth Q/Q | +32.1% |
| Distance from 52-week high | +31.2% |
| Market cap (USD) | $100.7M |